Enroll Now
10 AMA PRA Category 1 Credits™ $179

Program expires 9/13/2022

Estimated time to complete activity: 10 hours

If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x814

Target Audience

This activity has been designed to meet the educational needs of physician assistants involved in the care of patients who are considering using medical marijuana as part of their care plan in States that recognize marijuana as a medical treatment.

Program Overview

The activity is an educational overview of medical cannabis in its current legal context in the US. Currently there are 2.1 million registered medical marijuana patients and there are an estimated 3.5 million patients using medical marijuana nationwide. The constantly changing legal environment in which cannabis can be used in the United States has resulted in confusion for both physicians and patients. Currently, 33 states have legalized medical marijuana and 10 states have also legalized recreational marijuana. Due to the lack of knowledge of the legality of discussing medical marijuana, physicians, nurses and pharmacists are hesitant to discuss with their patients. The lack of communication between the patient and physician can lead to the patient self-medicating with no guidance from a medical professional.

Learning Outcome

To have the knowledge to be able to discuss medical marijuana with a patient and determine if cannabinoids should be included in their treatment plan based on information that addresses current studies, legal developments, historical context, interaction with the Endocannabinoid System and side effects associated with marijuana use.

10 AMA PRA Category 1 Credits™ $179
Enroll Now

Program Agenda

  • Module 1: History and Legal Landscape
  • Module 2: The Discovery of the Endocannabinoid System
  • Module 3: The Endocannabinoid System
  • Module 4: Cannabinoids and Terpenes
  • Module 5: Studies on Therapeutic Uses
  • Module 6: Cannabis and Opioids in Chronic Pain Treatment
  • Module 7: Side Effects and Chronic Effects

Educational Objectives

After completing this activity, the participant should be better able to:

  • Interpret the legal context in which cannabis can be discussed with a patient and how states can have legalized medical marijuana even though it is recognized as a federally illegal substance.
  • Compare and relate the historical medicinal uses of marijuana to modern resurgence in patient use of medical marijuana.
  • Explain why there is a lack of clinical studies due to Schedule I classification of marijuana.
  • Summarize and explain the discovery of the Endocannabinoid System and how its discovery has led to further research into how cannabinoids interact with the receptors.
  • Summarize the function of the Endocannabinoid System in the regulation of the body through a vast network of receptors involved in maintaining homeostasis, neuroprotection, and other regulatory functions.
  • Discuss and interpret how cannabinoids and terpenes affect the Endocannabinoid receptor system.
  • Assess pros and cons of cannabinoids and their effects on the symptoms of ailments such as anxiety, chronic pain, epilepsy, gastrointestinal disorders, neurodegenerative illnesses, post-traumatic stress and migraines.
  • Evaluate the current research studies regarding opioids versus cannabinoids in the treatment of the symptoms of chronic pain.
  • Discuss side effects and contraindications of medicinal cannabis and safety concerns with its use.
  • Identify signs of abuse, misuse and chronic effects of marijuana use.

Physician Credit

Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.   Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 10 contact hours (1.0 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event.  Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time.  The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.

Credit Designation

SynAptiv designates this enduring material for a maximum of 10 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

UAN  # 0761-9999-20-239-H01-P; 0761-9999-20-239-H01-T
Program expires 9/13/2022 

Estimated time to complete activity: 10 hours

If you are a medical group or network and need multi-seat pricing, please call 844.411.0500 x814

10 AMA PRA Category 1 Credits™ $179
Enroll Now

Course Materials

  • 10 AMA PRA Category 1 Credits™
  • Instant access to all course materials
  • Printable and downloadable infographics
  • All research materials used for the online course
  • Lifetime, unlimited access
  • 24/7 access
  • No time limits
  • Start anytime
  • Work on your own time and at your own pace
  • Affordably priced


Dr. Gregory Smith


Dr. Gregory Smith has been in primary care practice for over 30 years. He is board certified in Preventive Medicine and obtained his MPH from Harvard University. He first trained on the use of medical cannabis in 2000 in California. He has written extensively on the subject, including his popular textbook, “Medical Cannabis: Basic Science and Clinical Applications” published in 2016, and more recently “Cannabidiol, CBD: What you need to know.” And most recently in 2019, “THCV: Appetite Killer.”

Dr. Kevin Smith


Dr. Kevin Smith has also been in primary care practice for over 30 years.  He is board certified in Preventive Medicine and obtained his MPH from Yale University.  He trained on the use of medical Cannabis several years ago and has been very active in educating physicians and other medical professionals.

Disclosure of Conflicts of Interest

It is the policy of SynAptiv to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by SynAptiv to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

This activity is jointly provided by SynAptiv and Medical Marijuana 411.